Houliston D C, Boyd C M, Nicholas D S, Smith J A
Department of Cytology, Royal Bournemouth NHS Trust, UK.
Cytopathology. 1998 Jun;9(3):162-70. doi: 10.1046/j.1365-2303.1998.00127.x.
In our laboratory, which processes approximately 40,000 smears annually, the reporting patterns of each individual primary screener have been continuously monitored over a 6-year period. The detection rates for minor abnormalities (borderline/mild dyskaryosis) and major abnormalities (moderate dyskaryosis and worse) are published quarterly in the laboratory. Individual continuous monitoring rapidly identifies screeners with low detection rates. It is a useful adjunct to existing methods of quality assurance; rescreening can be more appropriately directed to smears reported by screeners with low detection rates. It also identifies training needs and may be used to assess the value of update courses for each screener. It is a faster method of identifying poor performance than rapid review of all smears. The reporting rate of inadequate smears is also calculated and published on a quarterly basis. This promotes a degree of uniformity within the laboratory in the rate at which smears are reported as inadequate, and also reduces the inadequate rate.
在我们实验室，每年处理约40000份涂片，在6年期间持续监测了每位初级筛查人员的报告模式。实验室每季度公布轻微异常（临界/轻度核异质）和重大异常（中度核异质及更严重情况）的检出率。个体持续监测能迅速识别出检出率低的筛查人员。它是现有质量保证方法的有益补充；重新筛查可以更合理地针对检出率低的筛查人员报告的涂片。它还能确定培训需求，并可用于评估每位筛查人员进修课程的价值。与快速审查所有涂片相比，它是一种更快识别表现不佳人员的方法。不充分涂片的报告率也会每季度计算并公布。这促进了实验室内部在将涂片报告为不充分的比率方面的一定程度的一致性，同时也降低了不充分率。
